METROPOLITAN LIFE INSURANCE CO/NY - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 217 filers reported holding FATE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.6%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,593
-55.5%
4,5250.0%0.00%
-100.0%
Q2 2023$21,539
-16.5%
4,5250.0%0.00%0.0%
Q1 2023$25,793
-48.6%
4,525
-9.0%
0.00%
-50.0%
Q4 2022$50,167
-55.0%
4,9720.0%0.00%
-60.0%
Q3 2022$111,423
-9.6%
4,9720.0%0.01%0.0%
Q2 2022$123,206
-36.1%
4,9720.0%0.01%
-28.6%
Q1 2022$192,764
-84.3%
4,972
-76.3%
0.01%
-58.8%
Q4 2021$1,227,481
-5.2%
20,979
-4.0%
0.02%
-10.5%
Q3 2021$1,294,694
-31.0%
21,844
+1.1%
0.02%
-26.9%
Q2 2021$1,875,185
+12.4%
21,606
+6.7%
0.03%
+4.0%
Q1 2021$1,669,035
-8.0%
20,243
+1.5%
0.02%
-7.4%
Q4 2020$1,813,599
+118.4%
19,945
-4.0%
0.03%
+80.0%
Q3 2020$830,297
+26.6%
20,773
+8.7%
0.02%
+25.0%
Q2 2020$655,870
+60.2%
19,116
+3.7%
0.01%
+33.3%
Q1 2020$409,330
+6.7%
18,430
-6.0%
0.01%
+50.0%
Q4 2019$383,572
+26.0%
19,6000.0%0.01%
+20.0%
Q3 2019$304,388
-26.6%
19,600
-4.0%
0.01%
-28.6%
Q2 2019$414,587
+15.5%
20,4230.0%0.01%0.0%
Q1 2019$358,832
+36.9%
20,4230.0%0.01%
+40.0%
Q4 2018$262,027
-2.3%
20,423
+24.0%
0.01%0.0%
Q3 2018$268,247
-99.9%
16,4670.0%0.01%
+66.7%
Q2 2018$186,736,000
+21.1%
16,467
+4.2%
0.00%
+50.0%
Q1 2018$154,198,00015,7990.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$131,006,00024.77%
Redmile Group, LLC 12,957,222$502,351,00015.68%
Grosvenor Holdings, L.L.C. 1,037,256$40,214,0007.85%
Casdin Capital, LLC 3,400,000$131,818,0005.91%
Ally Bridge Group (NY) LLC 181,500$7,037,0005.22%
DAFNA Capital Management LLC 500,930$19,421,0005.06%
Deep Track Capital, LP 2,000,000$77,540,0004.97%
Artal Group S.A. 2,000,000$77,540,0003.25%
Tri Locum Partners LP 190,345$7,380,0002.88%
ARK Investment Management 10,988,182$426,012,0001.78%
View complete list of FATE THERAPEUTICS INC shareholders